4151

Kyowa Kirin
4151

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥1.30T
EV
¥1.11T
Shares Outstanding
523.38M
Beta
0.15

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
¥2540.91
P/E 2025E
23.34x
P/Revenue 2025E
2.74x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Kyowa Kirin Co., Ltd.

gainify
4151

Kyowa Kirin Co., Ltd.

4151

Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asi...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Miyamoto, Masashi

Employees

5,669

IPO Date

2000-01-04

Headquarters

Otemachi Financial City Grand Cube, 1-9-2, Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.